Skip to main content

Advertisement

Log in

TERT Promoter Mutation and Telomere Length in Salivary Gland Tumors

  • Letter to the Editor
  • Published:
Pathology & Oncology Research

An Erratum to this article was published on 04 September 2017

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Change history

  • 04 September 2017

    An erratum to this article has been published.

References

  1. Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339(6122):959–961. doi:10.1126/science.1230062

    Article  PubMed  CAS  Google Scholar 

  2. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339(6122):957–959. doi:10.1126/science.1229259

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Qu Y, Shi L, Wang D, Zhang B, Yang Q, Ji M, Shi B, Hou P (2014) Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers. Int J Cancer 134(12):2993–2994. doi:10.1002/ijc.28633

    Article  PubMed  CAS  Google Scholar 

  4. Lee H, Jin J-D, La B-M, Park W-J, Choi I-J, Lee J-H (2016) TERT promoter mutation, telomere length, and TERT expression in gastric cancer. Int J Clin Exp Pathol 9(2):1758–1763

    CAS  Google Scholar 

  5. Liu T, Wang N, Cao J, Sofiadis A, Dinets A, Zedenius J, Larsson C, Xu D (2014) The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas. Oncogene 33(42):4978–4984. doi:10.1038/onc.2013.446

    Article  PubMed  CAS  Google Scholar 

  6. Borah S, Xi L, Zaug AJ, Powell NM, Dancik GM, Cohen SB, Costello JC, Theodorescu D, Cech TR (2015) Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science 347(6225):1006–1010. doi:10.1126/science.1260200

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Oh C-M, Won Y-J, Jung K-W, Kong H-J, Cho H, Lee J-K, Lee DH, Lee KH, Community of Population-Based Regional Cancer R (2016) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat 48(2):436–450. doi:10.4143/crt.2016.089

    Article  PubMed  PubMed Central  Google Scholar 

  8. Schache AG, Hall G, Woolgar JA, Nikolaidis G, Triantafyllou A, Lowe D, Risk JM, Shaw RJ, Liloglou T (2010) Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma. Br J Cancer 103(12):1846–1851. doi:10.1038/sj.bjc.6605953

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyunsu Lee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, H., Ahn, D., Sohn, J.H. et al. TERT Promoter Mutation and Telomere Length in Salivary Gland Tumors. Pathol. Oncol. Res. 24, 697–698 (2018). https://doi.org/10.1007/s12253-017-0275-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-017-0275-6

Navigation